HKSE:2666

Genertec Universal Medical Group Company Limited · HKSE · Financial Services · HKD · FY for 2025

Figures on this page computed 2026-11-08 13:27 UTC

Last close

n/aHKD

Market data

3.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
HKD
- computed
- Computed from the filing for 2025
14.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
15.2%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
21.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
2.60Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
7.6%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
HKD
- computed

Growth is the furthest below its sector's middle: 0.47 against 0.56 on the market's range.

All from 100

lens 2 of 9

Sales

537

2016-12-31 to 2025-12-31100 at the start537

Sales: 100.00 on 2016-12-31 to 536.74 on 2025-12-31, up 437%.

Profit

253

2016-12-31 to 2025-12-31100 at the start253

Profit: 100.00 on 2016-12-31 to 253.23 on 2025-12-31, up 153%.

Shares in issue

117

2016-12-31 to 2025-12-31100 at the start117

Shares in issue: 100.00 on 2016-12-31 to 117.29 on 2025-12-31, up 17%.

Sales is at 537, Profit is at 253, Shares in issue is at 117, against 100 in 2016.

Sales is at 537, Profit is at 253, Shares in issue is at 117, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100537
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100253
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100117
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY